Abstract

Advanced Glycation End Products (AGEs) has been implicated in the progression of diabetic keratopathy. However, details regarding their function are not well understood. In the present study, we investigated the effects of intracellular reactive oxygen species (ROS) and JNK, p38 MAPK on AGE-modified bovine serum albumin (BSA) induced Human telomerase-immortalized corneal epithelial cells (HUCLs) apoptosis. We found that AGE-BSA induced HUCLs apoptosis and increased Bax protein expression, decreased Bcl-2 protein expression. AGE-BSA also induced the expression of receptor for advanced glycation end product (RAGE). AGE-BSA-RAGE interaction induced intracellular ROS generation through activated NADPH oxidase and increased the phosphorylation of p47phox. AGE-BSA induced HUCLs apoptosis was inhibited by pretreatment with NADPH oxidase inhibitors, ROS quencher N-acetylcysteine (NAC) or neutralizing anti-RAGE antibodies. We also found that AGE-BSA induced JNK and p38 MAPK phosphorylation. JNK and p38 MAPK inhibitor effectively blocked AGE-BSA-induced HUCLs apoptosis. In addition, NAC completely blocked phosphorylation of JNK and p38 MAPK induced by AGE-BSA. Our results indicate that AGE-BSA induced HUCLs apoptosis through generation of intracellular ROS and activation of JNK and p38 MAPK pathways.

Highlights

  • Diabetes has become a public health problem of considerable magnitude [1].Diabetic keratopathy has been recognized as a serious complication of diabetes [2], such as persistent corneal epithelial defects, recurrent corneal erosion, persistent corneal edema and delayed corneal epithelial wound repair

  • We investigated whether Advanced Glycation End Products (AGEs)-modified bovine serum albumin (BSA) could induce apoptosis in Human telomerase-immortalized corneal epithelial cells (HUCLs), and determined the effect of intracellular reactive oxygen species (ROS) and JNK, p38 Mitogen-activated protein kinase (MAPK) on AGE-BSA induced Human telomeraseimmortalized corneal epithelial cells (HUCLs) apoptosis

  • HUCLs were incubated with 200 mg/ml of AGE-BSA for 6, 12, 24 and 48 h or treated with 50, 100 and 200 mg/ml of AGE-BSA for 24 h

Read more

Summary

Introduction

Diabetic keratopathy has been recognized as a serious complication of diabetes [2], such as persistent corneal epithelial defects, recurrent corneal erosion, persistent corneal edema and delayed corneal epithelial wound repair. For diabetic retinopathy patients undergoing vitrectomy, the removal of the corneal epithelium during the procedure results in a considerable delay in corneal epithelial wound healing [3]. Proper healing of corneal epithelial wounds is vital for maintaining a clear cornea and preserving vision. Delayed healing of corneal epithelial wound may cause sight-threatening complications, such as ocular surface irregularity, microbial keratitis or even blindness. There is no effective strategy for the treatment of diabetic keratopathy in clinical practice [4]. Delineating the underlying mechanisms of diabetic keratopathy will be of great clinical value

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call